MAIA Biotechnology
MAIA
20 hedge funds and large institutions have $3.95M invested in MAIA Biotechnology in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 0 reducing their positions, and 4 closing their positions.
75% more capital invested
Capital invested by funds: $2.26M → $3.95M (+$1.69M)
2.54% more ownership
Funds ownership: 4.99% → 7.54% (+2.5%)
0% more funds holding
Funds holding: 20 → 20 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWM
Centric Wealth Management
Chicago,
Illinois
|
+$904K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$878K |
| 3 |
Jane Street
New York
|
+$51.5K |
| 4 |
State Street
Boston,
Massachusetts
|
+$39.9K |
| 5 |
BlackRock
New York
|
+$34.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HFF
Halter Ferguson Financial
Carmel,
Indiana
|
-$363K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$84.3K |
| 3 |
NW
Naviter Wealth
Little Rock,
Arkansas
|
-$16.2K |
| 4 |
BWM
Bernard Wealth Management
Royal Oak,
Michigan
|
-$765 |
MAIA Hedge Fund Activity: Q2 2025 in Review
20 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in MAIA Biotechnology (MAIA) for Q2 2025, worth a combined $3.95M — up 75% from $2.26M a quarter earlier.
Fund positioning in MAIA was balanced in Q2 2025: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 0 trimmed.
The largest buyer was Centric Wealth Management, adding an estimated $904K. The largest seller was Halter Ferguson Financial, exiting entirely with an estimated $363K sold.
- 20 institutional investors held MAIA Biotechnology (MAIA) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $3.95M of MAIA Biotechnology stock for Q2 2025, up 75% quarter-over-quarter.
- 4 funds opened new MAIA Biotechnology positions in Q2 2025 and 4 closed out, a net change of 0 holders.
- The largest MAIA Biotechnology buyer in Q2 2025 was Centric Wealth Management, an estimated $904K added.
- The largest MAIA Biotechnology seller in Q2 2025 was Halter Ferguson Financial, an estimated $363K sold.
Based on aggregated 13F filings for Q2 2025.